SCHEMBL2993064

SCHEMBL2993064

c1ccc(Oc2ccc([I+]c3ccccc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 7/20 0.60
TSHR P16473 1/20 0.60
NR1H2 P55055 1/20 0.52
BAX Q07812 1/20 0.52
MAOA P21397 1/20 0.52
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
KDM1A O60341 1/20 0.45
GSTP1 P09211 1/20 0.43
SOS1 Q07889 1/20 0.43
CA9 Q16790 1/20 0.43
PARP10 Q53GL7 1/20 0.43
PLA2G2A P14555 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
NLRP3 Q96P20 1/20 0.42
SRD5A2 P31213 1/20 0.42
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12502854 0.97 LTA4H (0.63) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL10022956 0.89 LTA4H (0.52) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL1134076 0.89 LTA4H (0.52) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL4444572 0.87 HTT (0.56) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL17103724 0.85 LTA4H (0.48) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL4644201 0.83 LTA4H (0.41) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL91964 0.82 LTA4H (0.45) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL30516325 0.81 LTA4H (0.55) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL3893562 0.81 LTA4H (0.92) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL12762155 0.81 ALDH1A1 (0.38) TSHRMAOACA1CA2KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3593786-B1 PHOTOCURABLE COMPOSITION AND DENTAL RESTORATION FILLING MATERIAL TOKUYAMA DENTAL CORP (JP) 2022-05-18 EP claimed
US-20260035592-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT TOKUYAMA DENTAL CORPORATION (JP) 2026-02-05 US disclosed
US-20250213434-A1 DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY KURARAY NORITAKE DENTAL INC. (JP) 2025-07-03 US disclosed
US-20250101205-A1 COMPOSITE OXIDE PARTICLES, METHOD FOR PRODUCING SAME, AND CURABLE COMPOSITION TOKUYAMA DENTAL CORPORATION (JP) 2025-03-27 US disclosed
EP-4505992-A1 DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY Kuraray Noritake Dental Inc. (JP) 2025-02-12 EP disclosed
EP-4470975-A1 COMPOSITE OXIDE PARTICLES, METHOD FOR PRODUCING SAME, AND CURABLE COMPOSITION Tokuyama Dental Corporation (JP) 2024-12-04 EP disclosed
EP-4091578-B1 METHOD FOR PRODUCING PLATE DENTURE TOKUYAMA DENTAL CORP (JP) 2024-10-09 EP disclosed
US-20240180788-A1 PHOTOCATIONICALLY CURABLE COMPOSITION TOKUYAMA DENTAL CORPORATION (JP) 2024-06-06 US disclosed
WO-2024038705-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR 3D STEREOLITHOGRAPHY AND METHOD FOR PRODUCING 3D STEREOLITHOGRAPHY PRODUCT 株式会社トクヤマデンタル 2024-02-22 WO disclosed
EP-4310128-A1 PHOTOCATIONICALLY CURABLE COMPOSITION Tokuyama Dental Corporation (JP) 2024-01-24 EP disclosed
EP-1422254-B1 Photocationic polymerization initiator and photocationically polymerizable composition TOKUYAMA CORP (JP) 2008-06-18 EP disclosed
US-7365106-B2 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2008-04-29 US disclosed
EP-1431315-B1 Photopolymerization initiator and photopolymerizable composition TOKUYAMA CORP (JP) 2007-10-17 EP disclosed
US-20050250868-A1 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2005-11-10 US disclosed
EP-1591098-A1 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2005-11-02 EP disclosed
US-6930134-B2 Photocationic polymerization initiator and photocationically polymerizable composition TOKUYAMA CORPORATION (JP) 2005-08-16 US disclosed
US-20040186195-A1 Photopolymerization initiator and photopolymerizable composition TOKUYAMA CORPORATION (JP) 2004-09-23 US disclosed
US-20040132853-A1 Photocationic polymerization initiator and photocationically polymerizable composition TOKUYAMA CORPORATION (JP) 2004-07-08 US disclosed
EP-1431315-A2 Photopolymerization initiator and photopolymerizable composition Tokuyama Corporation (JP) 2004-06-23 EP disclosed
EP-1422254-A2 Photocationic polymerization initiator and photocationically polymerizable composition Tokuyama Corporation (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240180788-A1 PHOTOCATIONICALLY CURABLE COMPOSITION CRY1, CRY2, TYR LTA4H 629/4885TSHR 4550/4885NR1H2 4865/4885
US-20260035592-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT TERB1, CAD, C9 LTA4H 199/4885TSHR 2090/4885NR1H2 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.